Healthcare & Genomics
Build and commercialize precision-health, genomics, pharmacogenomics, clinical-information, and longitudinal-care capabilities designed to support providers, patients, and healthcare organizations.
The Convergence of Healthcare, Wealth & Trust Infrastructure
Renoviant is a technology-enabled private equity parent and integrated enterprise infrastructure platform. We build, acquire, integrate, commercialize, and scale businesses across healthcare, genomics, artificial intelligence, digital identity, distribution, financial services, capital, and trust infrastructure.
Three Platforms. One Enterprise.
About Renoviant
Building an
Integrated Enterprise
Renoviant connects capabilities that markets can no longer afford to keep fragmented.
Renoviant develops and integrates businesses that address the growing convergence of healthcare, technology, capital, identity, data, and trust. The enterprise combines strategic ownership with shared operating capabilities designed to move promising ideas and companies from development through commercialization and scale.
Across the portfolio, Renoviant supports enterprise strategy, business development, commercialization, technology, provider engagement, distribution, capital formation, and long-term growth. Its operating areas include genomics, precision health, artificial intelligence, trusted identity and consent, provider infrastructure, specialty healthcare networks, pharmaceutical and consumer-health products, research, intellectual property, financial services, and capital.
The result is one enterprise designed to create stronger companies, more efficient infrastructure, and durable long-term value.
What We Do
Six operating capabilities, shared across the enterprise.
Technology & Intelligence
Develop the intelligence, software, data, workflow, automation, and digital infrastructure that connect the enterprise and improve decision-making, security, scalability, and user experience.
Distribution & Commercial Services
Provide distribution, fulfillment, commercialization, consulting, product support, funding solutions, and financial services through FirstSource and related enterprise capabilities.
Provider & Specialty Networks
Develop provider acquisition, education, enablement, engagement, and specialty-network infrastructure, including pediatric, women's-health, and men's-health strategies.
Financial & Capital Infrastructure
Connect enterprise development with capital formation, investment strategy, financial services, and selected financial infrastructure, including Goldrok Bank.
Research & Product Development
Advance scientific, pharmaceutical, consumer-health, and intellectual-property opportunities through focused research, development, partnerships, and commercialization.
Selected Enterprise Companies
Platforms, networks, and infrastructure.
A selection of companies and platforms within the Renoviant enterprise. Each operates within a shared architecture of strategy, technology, commercialization, and capital.
PRECISO™
Precision health · GenomicsPrecision-health and genomics platform focused on converting genomic and clinical intelligence into actionable, longitudinal healthcare insight.
FirstSource™
Distribution · Commercial · Financial servicesDistribution, fulfillment, commercialization, consulting, funding solutions, and financial-services platform supporting the Renoviant enterprise and external partners.
VeriCense™
Identity · Consent · Trust infrastructureTrusted identity, consent, governance, security, access, wallet, vault, and ledger infrastructure designed for responsible participation across connected systems.
PHIN™ / PHIN Central™
Provider access · EnablementProvider-access, education, credentialing, enablement, activation, and engagement infrastructure supporting enterprise healthcare programs.
Renoviant Intelligence™ / VeraMind™
Artificial intelligence · AnalyticsEnterprise intelligence and artificial-intelligence capabilities supporting workflows, analytics, automation, decision-making, and scale.
ixurance™
Risk · Benefit architecturePrecision-health risk and benefit architecture designed to connect clinical insight, prevention, trusted data, and aligned economic participation.
Immune Bioscience™
Research · Intellectual propertyResearch, scientific development, and intellectual-property platform supporting selected therapeutic, diagnostic, and product-development opportunities.
Goldrok Bank
Financial · Banking infrastructureSelected financial and banking infrastructure within Renoviant's broader capital and financial-services strategy.
More to Come
Specialty network strategies
Initelis™
Pediatric health-network strategy.
Femulis™
Women's health-network strategy.
Masculis™
Men's health-network strategy.
Companies, platforms, and initiatives described above are at differing stages of development and deployment.
Leadership
Carlos Alfaras
Creator, Chairman & Chief Executive Officer
Carlos Alfaras leads Renoviant's enterprise strategy, architecture, commercialization, capital development, and integration across its operating companies, platforms, networks, and strategic initiatives.
Contact Renoviant
Start a Conversation
Renoviant engages with strategic partners, healthcare organizations, providers, technology companies, product and distribution partners, capital sources, and enterprises seeking integrated commercialization and infrastructure capabilities.
- Location
- Miami, Florida 33177
- Response
- Routed to the appropriate team member
Thank you for contacting Renoviant. Your inquiry has been received and will be routed to the appropriate member of our team.
The Evolution Continues
Renoviant continues to build, integrate, commercialize, and scale companies designed for the future of healthcare, technology, capital, and trust.
Build with purpose.
Commercialize deliberately.
Integrate by design.